Log in to save to my catalogue

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies i...

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ad3c445f15d4d4c8f608c8aec50d49f

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma

About this item

Full title

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2025-05, Vol.15 (1), p.83-4, Article 83

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6ad3c445f15d4d4c8f608c8aec50d49f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6ad3c445f15d4d4c8f608c8aec50d49f

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-025-01284-y

How to access this item